Martinez-Reyes I, Cardona LR, Kong H, et al. Mitochondrial ubiquinol oxidation is necessary for tumour growth. Nature 2020.
Corresponding author(s): Navdeep S Chandel
The mitochondrial electron transport chain (ETC) is necessary for tumour growth and its inhibition has demonstrated anti-tumour efcacy in combination with targeted therapies . Furthermore, human brain and lung tumours display robust glucose oxidation by mitochondria. However, it is unclear why a functional ETC is necessary for tumour growth in vivo. ETC function is coupled to the generation of ATP—that is, oxidative phosphorylation and the production of metabolites by the tricarboxylic acid (TCA) cycle. Mitochondrial complexes I and II donate electrons to ubiquinone, resulting in the generation of ubiquinol and the regeneration of the NAD+ and FAD cofactors, and complex III oxidizes ubiquinol back to ubiquinone, which also serves as an electron acceptor for dihydroorotate dehydrogenase (DHODH)—an enzyme necessary for de novo pyrimidine synthesis. Here we show impaired tumour growth in cancer cells that lack mitochondrial complex III. This phenotype was rescued by ectopic expression of Ciona intestinalis alternative oxidase (AOX)12, which also oxidizes ubiquinol to ubiquinone. Loss of mitochondrial complex I, II or DHODH diminished the tumour growth of AOX-expressing cancer cells deficient in mitochondrial complex III, which highlights the necessity of ubiquinone as an electron acceptor for tumour growth. Cancer cells that lack mitochondrial complex III but can regenerate NAD+ by expression of the NADH oxidase from Lactobacillus brevis (LbNOX)13 targeted to the mitochondria or cytosol were still unable to grow tumours. This suggests that regeneration of NAD+ is not suffcient to drive tumour growth in vivo. Collectively, our fndings indicate that tumour growth requires the ETC to oxidize ubiquinol, which is essential to drive the oxidative TCA cycle and DHODH activity.
線粒體電子傳遞鏈對(duì)于腫瘤生長(zhǎng)是必需的。并且它的抑制作用已經(jīng)在聯(lián)合靶向治療中證實(shí)了抗腫瘤的療效。其次,人類(lèi)大腦和肺部腫瘤,線粒體會(huì)氧化大量的葡萄糖。然而,為何一個(gè)功能性的電子傳遞鏈在體內(nèi)對(duì)于腫瘤的生長(zhǎng)是必需的,這仍然不清楚。ETC的功能是與ATP的產(chǎn)生相耦合---也就是氧化磷酸化,以及產(chǎn)生三羧酸循環(huán)的代謝物。線粒體復(fù)合體I和II將電子傳遞給泛醌,導(dǎo)致了泛醇的產(chǎn)生以及NAD+和FAD輔酶因子的再生,并且復(fù)合體III氧化泛醇,使之回至泛醌,它也是二氫乳清酸脫氫酶的電子受體(DHODH)-----這是嘧啶合成時(shí)所必需的酶。在這里,我們證實(shí)了癌細(xì)胞中缺乏線粒體復(fù)合體III會(huì)抑制腫瘤生長(zhǎng)。而這種表型可以被異位表達(dá)玻璃海鞘替代氧化酶(AOX)挽救,AOX也可以將泛醇氧化為泛醌。線粒體復(fù)合物I、II或二氫乳清酸脫氫酶(DHODH)的缺失使得線粒體復(fù)合物III缺乏且表達(dá)AOX的癌細(xì)胞的生長(zhǎng)受損,這突出了泛醌作為腫瘤生長(zhǎng)電子受體的必要性。缺乏線粒體復(fù)合物III但是可以通過(guò)來(lái)自短乳桿菌(LbNOX)的靶向于線粒體細(xì)胞質(zhì)的NADH氧化酶再生NAD+的癌細(xì)胞仍然無(wú)法生長(zhǎng)。這意味著NAD+的再生并不是使腫瘤細(xì)胞生長(zhǎng)所必要的。因此,我們的結(jié)果表明,腫瘤生長(zhǎng)需要ETC來(lái)氧化泛醇,這對(duì)于驅(qū)動(dòng)氧化三羧酸循環(huán)和DHODH活性至關(guān)重要。
聯(lián)系客服